Cell-free nucleic acids as biomarkers in cancer patients

被引:2246
作者
Schwarzenbach, Heidi [1 ]
Hoon, Dave S. B. [2 ]
Pantel, Klaus [1 ]
机构
[1] Univ Med Ctr Hamburg Eppendorf, Ctr Med Expt, Inst Tumour Biol, D-20246 Hamburg, Germany
[2] John Wayne Canc Inst, Dept Mol Oncol, Santa Monica, CA 90404 USA
基金
美国国家卫生研究院;
关键词
BARR-VIRUS DNA; CIRCULATING TUMOR-CELLS; CPG ISLAND HYPERMETHYLATION; BLOOD-BASED MARKERS; FREE SERUM DNA; PLASMA DNA; COLORECTAL-CANCER; BREAST-CANCER; QUANTITATIVE-ANALYSIS; PROSTATE-CANCER;
D O I
10.1038/nrc3066
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
DNA, mRNA and microRNA are released and circulate in the blood of cancer patients. Changes in the levels of circulating nucleic acids have been associated with tumour burden and malignant progression. In the past decade a wealth of information indicating the potential use of circulating nucleic acids for cancer screening, prognosis and monitoring of the efficacy of anticancer therapies has emerged. In this Review, we discuss these findings with a specific focus on the clinical utility of cell-free nucleic acids as blood biomarkers.
引用
收藏
页码:426 / 437
页数:12
相关论文
共 183 条
[1]   Role of cell-free plasma DNA as a diagnostic marker for prostate cancer [J].
Allen, D ;
Butt, A ;
Cahill, D ;
Wheeler, M ;
Popert, R ;
Swaminathan, R .
CIRCULATING NUCLEIC ACIDS IN PLASMA/SERUM III AND SERUM PROTEOMICS, 2004, 1022 :76-80
[2]  
An Q, 2002, CANCER LETT, V188, P109, DOI 10.1016/S0304-3835(02)00496-2
[3]  
[Anonymous], CA CANC J CLIN, DOI DOI 10.3322/CAAC.20107
[4]   Direct Serum Assay for MicroRNA-21 Concentrations in Early and Advanced Breast Cancer [J].
Asaga, Sota ;
Kuo, Christine ;
Nguyen, Tung ;
Terpenning, Marilou ;
Giuliano, Armando E. ;
Hoon, Dave S. B. .
CLINICAL CHEMISTRY, 2011, 57 (01) :84-91
[5]   Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients [J].
Au, WY ;
Pang, A ;
Choy, C ;
Chim, CS ;
Kwong, YL .
BLOOD, 2004, 104 (01) :243-249
[6]   MicroRNAs: Target Recognition and Regulatory Functions [J].
Bartel, David P. .
CELL, 2009, 136 (02) :215-233
[7]   Evaluation of circulating thyroid-specific transcripts as markers of thyroid cancer relapse [J].
Barzon, L ;
Boscaro, M ;
Pacenti, M ;
Taccaliti, A ;
Palù, G .
INTERNATIONAL JOURNAL OF CANCER, 2004, 110 (06) :914-920
[8]   Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy [J].
Bastian, PJ ;
Palapattu, GS ;
Lin, XH ;
Yegnasubramanian, S ;
Mangold, LA ;
Trock, B ;
Eisenberger, MA ;
Partin, AW ;
Nelson, WG .
CLINICAL CANCER RESEARCH, 2005, 11 (11) :4037-4043
[9]  
Bearzatto A, 2002, CLIN CANCER RES, V8, P3782
[10]   CIRCULATING DNA AS A POSSIBLE FACTOR IN ONCOGENESIS [J].
BENDICH, A ;
WILCZOK, T ;
BORENFREUND, E .
SCIENCE, 1965, 148 (3668) :374-+